Dr. Nicholas Vincent Rosende, MD

Dr. Rosende practices at HCA Florida Kendall Hospital in Miami, Florida, part of HCA Healthcare.

Dr. Rosende's NPI, 1700374915, was assigned on April 24, 2018. Dr. Rosende graduated from New York Medical College in 2018. Dr. Rosende holds Florida license ME148923.

Dr. Rosende's primary practice is HCA Florida Kendall Hospital, at 11750 Bird Rd, Miami, FL 33175 in Miami-Dade County. The practice phone is (305) 223-3000.

Dr. Rosende's primary practice is HCA Florida Kendall Hospital in Miami, Florida, part of HCA Healthcare. Dr. Rosende is also affiliated with Coral West Community Hospital. The medical group on file is Emergency Medicine Services of Florida. Dmand AI also links Dr. Rosende to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosende practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Rosende's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Rosende is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Rosende is licensed in Florida.

CMS data shows 213 Medicare services from Dr. Rosende across 4 procedure codes in 2024, for 165 Medicare patients. Medicare paid $26,790 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Rosende in 2024. The largest group is 85 and over, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 76% are also on Medicaid. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosende's median patient age at 41, with 59% women.

In 2024, Dr. Rosende wrote 133 Medicare Part D claims for 86 patients. 97% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $140 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

Dr. Rosende accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Rosende in 2023.

CMS Open Payments shows 4 general payments to Dr. Rosende from 3 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $334.

Dr. Rosende graduated from New York Medical College in 2018.

Dr. Rosende is in network with 4 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.